CD8A and COVID-19: By using orthogonal approaches, including activation-induced marker (AIM) analysis, intracellular cytokine staining, ELISPOT, and tetramer staining, it is possible to detect CD8+ T lymphocytes in the peripheral blood of about 70% of COVID-19 convalescent patients one month after infection.